MA35927B1 - Combination therapy for the treatment of ovarian cancer - Google Patents

Combination therapy for the treatment of ovarian cancer

Info

Publication number
MA35927B1
MA35927B1 MA37330A MA37330A MA35927B1 MA 35927 B1 MA35927 B1 MA 35927B1 MA 37330 A MA37330 A MA 37330A MA 37330 A MA37330 A MA 37330A MA 35927 B1 MA35927 B1 MA 35927B1
Authority
MA
Morocco
Prior art keywords
ovarian cancer
treatment
combination therapy
patient
chemotherapy
Prior art date
Application number
MA37330A
Other languages
French (fr)
Inventor
Corrado Bernasconi
David Bollag
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2013/054818 external-priority patent/WO2013135602A2/en
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MA35927B1 publication Critical patent/MA35927B1/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention concerne des méthodes de traitement d'un patient chez qui on a diagnostiqué un cancer de l'ovaire résistant au platine comprenant l'administration au dit patient d'une quantité efficace d'un anticorps anti-vegf et d'un agent chimiothérapique.The present invention relates to methods of treating a patient diagnosed with platinum-resistant ovarian cancer comprising administering to said patient an effective amount of an anti-vegf antibody and an agent. chemotherapy.

MA37330A 2012-03-13 2014-09-05 Combination therapy for the treatment of ovarian cancer MA35927B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261610128P 2012-03-13 2012-03-13
PCT/EP2013/054818 WO2013135602A2 (en) 2012-03-13 2013-03-11 Combination therapy for the treatment of ovarian cancer

Publications (1)

Publication Number Publication Date
MA35927B1 true MA35927B1 (en) 2014-12-01

Family

ID=53758581

Family Applications (1)

Application Number Title Priority Date Filing Date
MA37330A MA35927B1 (en) 2012-03-13 2014-09-05 Combination therapy for the treatment of ovarian cancer

Country Status (1)

Country Link
MA (1) MA35927B1 (en)

Similar Documents

Publication Publication Date Title
MA47313A (en) SUBCUTANEOUS FORMULATIONS OF HER2 ANTIBODIES
EA202091587A1 (en) ANTI-TIGIT ANTIBODIES AND THEIR APPLICATION AS THERAPEUTIC AND DIAGNOSTIC AGENTS
MA34059B1 (en) ANTI-ANGIOGENIC THERAPY FOR THE TREATMENT OF OVARIAN CANCER
EA201691023A1 (en) PEPTIDOMIMETIC CONNECTIONS AND THEIR CONJUGATES ANTIBODIES WITH MEDICINE
MA44312A (en) ANTIBODIES AND THEIR METHODS OF USE
EA201691059A1 (en) PEPTIDOMYMETICS COMPOUNDS AND THEIR CONJUGATES CONTAINING ANTIBODY AND MEDICINE
MA39094A1 (en) Combination therapy comprising an inhibitor of mdm2 and one or more additional pharmaceutically active principles for the treatment of cancers
BR112017003571A2 (en) combination therapy
EA201071421A1 (en) ANTI-FLT3 ANTIBODIES
UA113712C2 (en) FAP ANTIBODY AND METHODS OF ITS APPLICATION
EA201291260A1 (en) ANTIBODY AGAINST TROP-2 PERSON HAS ANTI-TUMOR ACTIVITY IN VIVO
EA202090510A1 (en) METHOD FOR TREATMENT OF LATERAL AMYOTROPHIC SCLEROSIS BY PRIDOPIDIN
MA47356A1 (en) Isochromene derivatives useful as inhibitors of phosphoinositide 3-kinases
UA113849C2 (en) THE APPLICATION OF SIGMA LIGANDS IN TYPE 2 PATIENTS WITH PAIN
MA38986A3 (en) Protein specific membrane antigen (psma) labeled inhibitors, their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer
MA37946A1 (en) Treatment of rheumatoid arthritis
MX360189B (en) Combination therapy for the treatment of glioblastoma.
EA201270124A1 (en) NEW THERAPEUTIC AND DIAGNOSTIC TOOLS
FR3034993B1 (en) UNIT PACKAGING, COMPOSITIONS AND THERAPEUTIC DIAGRAMS FOR THE ADMINISTRATION OF PRO-RESOLUTION PATHWAY STIMULATORS ON KERATINIC SURFACES
PH12014501543A1 (en) Combination therapy for the treatment of ovarian cancer
EA201490790A1 (en) Peptide Conjugates of Gastrin and Glyukagon Receptor Agonists
MA53069A1 (en) Igf-1r antibody and its use as a targeting vehicle for the treatment of cancer
EA202090116A1 (en) COMPOSITIONS CONTAINING CONJUGATES OF CANNABINOID ANALOGUE AND METHODS OF APPLICATION
MA35281B1 (en) Assay and administration of anti-erbb3 antibodies in combination with paclitaxel for the treatment of gynecological cancers
MA39146A1 (en) Combinations of Gabapentanoids and Sigma Receptor Ligands